Capital Raising

3cat raised US$4 million in Series A funding led by Foxmont Capital Partners with participation from Asian Development Bank and Golden Gate Ventures. ADB committed an additional US$2.8 million for future funding rounds. Funding will be used to expand from Malaysia into the Philippines.

Leadership read: 3cat's raise resets the leadership agenda more than the balance sheet. Capital into the sector buys room to build senior operating and commercial bench strength ahead of scale. The near-term tilt favours operators who have scaled before; the appointments that follow say more than the announcement did across Asia.

curated · 2026-09-23 · context →

CanSemi Technology, a Chinese chip foundry, is seeking to raise approximately $919 million (6.16 billion yuan) via IPO on the Shenzhen ChiNext board, capitalizing on Beijing's push for semiconductor self-reliance.

Leadership read: Fresh capital is a hiring signal before it is anything else. For CanSemi Technology Inc., a raise in the sector funds leadership depth, scale, go-to-market and operational rigour, rather than any single appointment. Watch where CanSemi Technology Inc. hires first across Asia; that is where the capital is really pointed.

curated · 2026-09-23 · context →

Rio.ai, an AI-powered quick-commerce platform for medicines and healthcare essentials, raised Rs 43.08 crore (~$5.2M USD) in pre-Series A funding led by Version One Ventures, with participation from Xeed Ventures, Good Capital, and Amplify Partner. Post-money valuation approximately Rs 170 crore.

Leadership read: Rio.ai's raise resets the leadership agenda more than the balance sheet. Capital into the sector buys room to build senior operating and commercial bench strength ahead of scale. The near-term tilt favours operators who have scaled before; the appointments that follow say more than the announcement did across Asia.

curated · 2026-09-23 · context →

Carro is in deliberations to conduct a dual listing on Nasdaq and Singapore Exchange (SGX), marking a significant capital-raising event via IPO.

Leadership read: Carro's raise resets the leadership agenda more than the balance sheet. Capital into the sector buys room to build senior operating and commercial bench strength ahead of scale. The near-term tilt favours operators who have scaled before; the appointments that follow say more than the announcement did across Asia.

curated · 2026-09-23 · context →

Chinese chipmaker CanSemi opened shares for public subscription on ChiNext, positioning to become ChiNext's first wafer foundry IPO. Signals capital raise via public markets and strategic domestic positioning

Leadership read: Fresh capital is a hiring signal before it is anything else. For CanSemi, a raise in the sector funds leadership depth, scale, go-to-market and operational rigour, rather than any single appointment. Watch where CanSemi hires first across Asia; that is where the capital is really pointed.

curated · 2026-09-23 · context →

Bluefors achieved unicorn status with €1B valuation and €217M in revenue, signaling successful growth trajectory and likely recent funding round or valuation event

Leadership read: Bluefors's raise resets the leadership agenda more than the balance sheet. Capital into the sector buys room to build senior operating and commercial bench strength ahead of scale. The near-term tilt favours operators who have scaled before; the appointments that follow say more than the announcement did across EMEA.

curated · 2026-09-23 · context →

Killa Brush (beauty/wellness brand) secured £2.65m investment from Arete

Leadership read: Fresh capital is a hiring signal before it is anything else. For Killa Brush, a raise in the sector funds leadership depth, scale, go-to-market and operational rigour, rather than any single appointment. Watch where Killa Brush hires first across EMEA; that is where the capital is really pointed.

curated · 2026-09-23 · context →

Éxxita Be Circular S A listed on Euronext Access Paris, a public market capital raise event.

Leadership read: Éxxita Be Circular S A's raise resets the leadership agenda more than the balance sheet. Capital into the sector buys room to build senior operating and commercial bench strength ahead of scale. The near-term tilt favours operators who have scaled before; the appointments that follow say more than the announcement did across EMEA.

curated · 2026-09-23 · context →

FEMSA successfully placed Senior Unsecured Bonds denominated in Swiss Francs on the Swiss bond market, listed on SIX Swiss Exchange.

Leadership read: FEMSA's raise resets the leadership agenda more than the balance sheet. Capital into the sector buys room to build senior operating and commercial bench strength ahead of scale. The near-term tilt favours operators who have scaled before; the appointments that follow say more than the announcement did across EMEA.

curated · 2026-09-23 · context →

Bristol-based carbon-storing wallboard technology company secured £4m funding package combining equity investment with UK and European innovation grants (EIC, Innovate UK). Second close targeting £1.3m remains open through end of 2026. Funding enables commercial licensing strategy and international manufacturing partnerships.

Leadership read: Adaptavate's raise resets the leadership agenda more than the balance sheet. Capital into the sector buys room to build senior operating and commercial bench strength ahead of scale. The near-term tilt favours operators who have scaled before; the appointments that follow say more than the announcement did across EMEA.

curated · 2026-09-23 · context →

UltraSight raised $24M in Series B2 financing led by Alive HealthTech Growth Fund to expand U.S. commercial deployment of AI-guided cardiac ultrasound platform and accelerate ICU/mechanical circulatory support workflows.

Leadership read: UltraSight's raise resets the leadership agenda more than the balance sheet. Capital into the sector buys room to build senior operating and commercial bench strength ahead of scale. The near-term tilt favours operators who have scaled before; the appointments that follow say more than the announcement did across Americas.

curated · 2026-09-23 · context →

Canadian government announced $67M in federal funding through Life Sciences Fund. Applied Pharmaceutical Innovation (API) is receiving nearly $22M toward a $23.5M initiative to launch the Canadian Allied Antimicrobial Supply Resilience project for securing antibiotic and antimicrobial drugs.

Leadership read: Applied Pharmaceutical Innovation's raise resets the leadership agenda more than the balance sheet. Capital into the sector buys room to build senior operating and commercial bench strength ahead of scale. The near-term tilt favours operators who have scaled before; the appointments that follow say more than the announcement did across Americas.

curated · 2026-09-23 · context →